Drug Delivery

  • Monika Schäfer-Korting

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 197)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Fundamentals

    1. Front Matter
      Pages 1-1
    2. Frank Alexis, Eric M. Pridgen, Robert Langer, Omid C. Farokhzad
      Pages 55-86
    3. Andrea A. Robitzki, Randy Kurz
      Pages 87-112
  3. Devices

    1. Front Matter
      Pages 113-113
    2. Eliana B. Souto, Rainer H. Müller
      Pages 115-141
    3. Regine Heilbronn, Stefan Weger
      Pages 143-170
    4. Andreas Henning, Stephanie Hein, Marc Schneider, Michael Bur, Claus-Michael Lehr
      Pages 171-192
    5. Mark A. F. Kendall
      Pages 193-219
    6. Juliane Hombach, Andreas Bernkop-Schnürch
      Pages 251-266
    7. Meital Zilberman, Amir Kraitzer, Orly Grinberg, Jonathan J. Elsner
      Pages 299-341
  4. Clinical and Preclinical Application of Therapeutics for Systemic Use

    1. Front Matter
      Pages 343-343
    2. Franz Gabor, Christian Fillafer, Lukas Neutsch, Gerda Ratzinger, Michael Wirth
      Pages 345-398
    3. Richard H. Guy
      Pages 399-410
  5. Clinical and Preclinical Application of Therapeutics for Topical Use

    1. Front Matter
      Pages 433-433
    2. Hans Christian Korting, Monika Schäfer-Korting
      Pages 435-468
    3. Tsutomu Yasukawa, Yuichiro Ogura
      Pages 469-489
  6. Erratum to: Biosensing and Drug Delivery at the Microscale

    1. Andrea A. Robitzki, Randy Kurz
      Pages 501-501
  7. Back Matter
    Pages 491-500

About this book


In the view of most experts pharmacology is on drugs, targets, and actions. In the context the drug as a rule is seen as an active pharmaceutical ingredient and not as a complex mixture of chemical entities of a well defined structure. Today, we are becoming more and more aware of the fact that delivery of the active compound to the target site is a key. The present volume gives a topical overview on various modern approaches to drug targeting covering today’s options for specific carrier systems allowing successful drug treatment at various sites of the body difficult to address and allowing to increase the benefit-risk-ratio to the optimum possible.


Biosensing Drug Delivery Drug-eluting implants Nanocarriers Targeted therapy clinical application

Editors and affiliations

  • Monika Schäfer-Korting
    • 1
  1. 1.FB Biologie, Chemie, Pharmazie, Inst. PharmazieFU BerlinBerlinGermany

Bibliographic information

Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods